Literature DB >> 27573805

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.

Lindsey M Weiner1, Amy K Webb1, Brandi Limbago1, Margaret A Dudeck1, Jean Patel1, Alexander J Kallen1, Jonathan R Edwards1, Dawn M Sievert1.   

Abstract

OBJECTIVE To describe antimicrobial resistance patterns for healthcare-associated infections (HAIs) that occurred in 2011-2014 and were reported to the Centers for Disease Control and Prevention's National Healthcare Safety Network. METHODS Data from central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonias, and surgical site infections were analyzed. These HAIs were reported from acute care hospitals, long-term acute care hospitals, and inpatient rehabilitation facilities. Pooled mean proportions of pathogens that tested resistant (or nonsusceptible) to selected antimicrobials were calculated by year and HAI type. RESULTS Overall, 4,515 hospitals reported that at least 1 HAI occurred in 2011-2014. There were 408,151 pathogens from 365,490 HAIs reported to the National Healthcare Safety Network, most of which were reported from acute care hospitals with greater than 200 beds. Fifteen pathogen groups accounted for 87% of reported pathogens; the most common included Escherichia coli (15%), Staphylococcus aureus (12%), Klebsiella species (8%), and coagulase-negative staphylococci (8%). In general, the proportion of isolates with common resistance phenotypes was higher among device-associated HAIs compared with surgical site infections. Although the percent resistance for most phenotypes was similar to earlier reports, an increase in the magnitude of the resistance percentages among E. coli pathogens was noted, especially related to fluoroquinolone resistance. CONCLUSION This report represents a national summary of antimicrobial resistance among select HAIs and phenotypes. The distribution of frequent pathogens and some resistance patterns appear to have changed from 2009-2010, highlighting the need for continual, careful monitoring of these data across the spectrum of HAI types. Infect Control Hosp Epidemiol 2016;1-14.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27573805      PMCID: PMC6857725          DOI: 10.1017/ice.2016.174

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  8 in total

1.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

2.  Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

Authors:  Lindsey M Weiner; Scott K Fridkin; Zuleika Aponte-Torres; Lacey Avery; Nicole Coffin; Margaret A Dudeck; Jonathan R Edwards; John A Jernigan; Rebecca Konnor; Minn M Soe; Kelly Peterson; L Clifford McDonald
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-03-11       Impact factor: 17.586

3.  National Healthcare Safety Network report, data summary for 2013, Device-associated Module.

Authors:  Margaret A Dudeck; Jonathan R Edwards; Katherine Allen-Bridson; Cindy Gross; Paul J Malpiedi; Kelly D Peterson; Daniel A Pollock; Lindsey M Weiner; Dawn M Sievert
Journal:  Am J Infect Control       Date:  2015-01-06       Impact factor: 2.918

4.  Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.

Authors:  Dawn M Sievert; Philip Ricks; Jonathan R Edwards; Amy Schneider; Jean Patel; Arjun Srinivasan; Alex Kallen; Brandi Limbago; Scott Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-27       Impact factor: 3.254

5.  Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.

Authors:  Marie-Hélène Nicolas-Chanoine; Jorge Blanco; Véronique Leflon-Guibout; Raphael Demarty; Maria Pilar Alonso; Maria Manuela Caniça; Yeon-Joon Park; Jean-Philippe Lavigne; Johann Pitout; James R Johnson
Journal:  J Antimicrob Chemother       Date:  2007-12-11       Impact factor: 5.790

6.  NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.

Authors:  Alicia I Hidron; Jonathan R Edwards; Jean Patel; Teresa C Horan; Dawn M Sievert; Daniel A Pollock; Scott K Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2008-11       Impact factor: 3.254

7.  Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.

Authors:  James R Johnson; Marie-Hélène Nicolas-Chanoine; Chitrita DebRoy; Mariana Castanheira; Ari Robicsek; Glen Hansen; Scott Weissman; Carl Urban; Joanne Platell; Darren Trott; George Zhanel; Connie Clabots; Brian D Johnston; Michael A Kuskowski
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

8.  Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.

Authors:  Nora Chea; Sandra N Bulens; Thiphasone Kongphet-Tran; Ruth Lynfield; Kristin M Shaw; Paula Snippes Vagnone; Marion A Kainer; Daniel B Muleta; Lucy Wilson; Elisabeth Vaeth; Ghinwa Dumyati; Cathleen Concannon; Erin C Phipps; Karissa Culbreath; Sarah J Janelle; Wendy M Bamberg; Alice Y Guh; Brandi Limbago; Alexander J Kallen
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

  8 in total
  301 in total

Review 1.  Treatment of Vancomycin-Resistant Enterococci: Focus on Daptomycin.

Authors:  Rose M Kohinke; Amy L Pakyz
Journal:  Curr Infect Dis Rep       Date:  2017-10       Impact factor: 3.725

2.  Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.

Authors:  J C Bader; E A Lakota; G E Dale; H S Sader; J H Rex; P G Ambrose; S M Bhavnani
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.

Authors:  Lindsey M Weiner-Lastinger; Sheila Abner; Jonathan R Edwards; Alexander J Kallen; Maria Karlsson; Shelley S Magill; Daniel Pollock; Isaac See; Minn M Soe; Maroya S Walters; Margaret A Dudeck
Journal:  Infect Control Hosp Epidemiol       Date:  2019-11-26       Impact factor: 3.254

4.  Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.

Authors:  Helio S Sader; Rodrigo E Mendes; Jennifer M Streit; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

5.  The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay.

Authors:  Pranita D Tamma; Abida Kazmi; Yehudit Bergman; Katherine E Goodman; Ernest Ekunseitan; Joe Amoah; Patricia J Simner
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

6.  Efficacy of a Multimechanistic Monoclonal Antibody Combination against Staphylococcus aureus Surgical Site Infections in Mice.

Authors:  Roger V Ortines; Yu Wang; Haiyun Liu; Dustin A Dikeman; Bret L Pinsker; Robert J Miller; Sophia E Kim; Nicole E Ackerman; Joe F Rizkallah; LeeAnn T Marcello; Taylor S Cohen; Christine Tkaczyk; Bret R Sellman; Lloyd S Miller
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 7.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

8.  In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.

Authors:  James A Karlowsky; Heather J Adam; Melanie R Baxter; Andrew J Denisuik; Philippe R S Lagacé-Wiens; Andrew J Walkty; Sailaja Puttagunta; Michael W Dunne; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

9.  Transcriptional Regulation of icaADBC by both IcaR and TcaR in Staphylococcus epidermidis.

Authors:  Tra-My Hoang; C Zhou; J K Lindgren; M R Galac; B Corey; J E Endres; M E Olson; P D Fey
Journal:  J Bacteriol       Date:  2019-02-25       Impact factor: 3.490

10.  Diversity of resistance mechanisms in carbapenem-resistant Enterobacteriaceae at a health care system in Northern California, from 2013 to 2016.

Authors:  Fiona Senchyna; Rajiv L Gaur; Johanna Sandlund; Cynthia Truong; Guillaume Tremintin; Dietmar Kültz; Carlos A Gomez; Fiona B Tamburini; Tessa Andermann; Ami Bhatt; Isabella Tickler; Nancy Watz; Indre Budvytiene; Gongyi Shi; Fred C Tenover; Niaz Banaei
Journal:  Diagn Microbiol Infect Dis       Date:  2018-10-13       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.